$BIEI Premier Biomedical Well Positioned in CBD
Post# of 102241
Premier Biomedical Well Positioned in CBD Market Expected to Exceed $22 Billion by 2022
Premier Biomedical Inc. (OTCQB: BIEI) - A research-based company which has developed multiple medical treatments and delivery systems for CBD oil in the human body for healing. Expands CBD Product Line Listen Now! - 52 Week High $0.56 - News Alert "Distributors" - Pain EX II Pain Medicine the Strongest Opioid Free OTC pain reliever on the Market Now! Time To Buy! Read More Now - http://www.thestreetnow.com/spotlight/biei/